Morgan Stanley 13D and 13G filings for Adverum Biotechnologies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 10:13 am Sale | 2023-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | MORGAN STANLEY MS | 515,050 5.100% | -198,456 (-27.81%) | Filing |
| 2023-02-08 2:48 pm Purchase | 2022-12-30 | 13G | Adverum Biotechnologies, Inc. ADVM | MORGAN STANLEY MS | 713,505 7.200% | 713,505 (New Position) | Filing |